Elfa Medicamentos board backs 2Q 2026 management report and quarterly results release

• Elfa Medicamentos held a board meeting on Aug. 13, 2026 to review management’s report and 2Q26 interim financial information.
• The board backed publication of the 2Q26 quarterly information, accompanied by the independent auditor’s report.
• Two directors abstained from the vote: José Roberto Correa Teixeira Ferraz, Sérgio Ricardo Leite Pereira.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elfa Medicamentos SA published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.